REMM-HIIT for Post-COVID-19 Critical Illness
(REMMHIIT-COVID Trial)
Trial Summary
What is the purpose of this trial?
This trial uses technology to remotely monitor and support high-intensity exercise for COVID-19 survivors. The goal is to help these patients rebuild their strength and fitness through short bursts of intense exercise.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment REMM-HIIT for Post-COVID-19 Critical Illness?
Is REMM-HIIT safe for humans?
How is the REMM-HIIT treatment different from other treatments for post-COVID-19 critical illness?
REMM-HIIT is unique because it combines high-intensity interval training with remote monitoring and mobile health support, allowing patients to exercise safely at home while being supervised digitally. This approach is novel compared to traditional rehabilitation methods, which often require in-person sessions and may not utilize technology for remote monitoring.456910
Research Team
Paul Wischmeyer, MD
Principal Investigator
Duke University
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in remotely monitored, mobile health-supported high intensity interval training (HIIT) 3 times a week, supplemented with strength, balance, and mobility exercises 2 times a week.
Follow-up
Participants are monitored for changes in biomarkers, physical performance, and cognitive function post-treatment.
Extended Follow-up
Participants' cognitive function and quality of life are assessed from 3 to 6 months post-discharge.
Treatment Details
Interventions
- REMotely Monitored, Mobile Health-Supported High Intensity Interval Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Vanderbilt University
Collaborator